ProShare Advisors’s Aura Biosciences AURA Stock Holding History

ProShare Advisors’s Portfolio AURA Stock Details AURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-10,830	Closed	-$59K	–	1879
2025 Q4	$59K	Buy	+10,830	New	+$64.3K	﹤0.01%	1938
2025 Q3	–	Sell	-10,003	Closed	-$62.6K	–	2014
2025 Q2	$62.6K	Sell	10,003 -2,290	-19%	-$13.4K	﹤0.01%	1967
2025 Q1	$72K	Sell	12,293 -3,134	-20%	-$23.7K	﹤0.01%	1896
2024 Q4	$127K	Buy	+15,427	New	+$145K	﹤0.01%	2019

Other funds holding AURA

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MVM

Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

ProShare Advisors's AURA Position: Q1 2026 in Review

ProShare Advisors sold out of Aura Biosciences (AURA) in Q1 2026, closing a stake of 10,830 shares — an estimated $59K sold.

ProShare Advisors first reported a position in AURA in Q4 2024 and held it in 4 quarters. The position peaked at $127K in Q4 2024. 126 funds tracked by Wall St. Rank hold AURA as of Q1 2026.

ProShare Advisors reported no remaining Aura Biosciences position as of Q1 2026 after selling out during the quarter.
ProShare Advisors sold 10,830 Aura Biosciences shares in Q1 2026, an estimated $59K.
ProShare Advisors first reported a position in Aura Biosciences in Q4 2024 and held it in 4 quarters.
ProShare Advisors's Aura Biosciences position peaked at $127K in Q4 2024.
126 funds tracked by Wall St. Rank held Aura Biosciences as of Q1 2026.

Based on ProShare Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.